The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 03, 2021

Filed:

Sep. 24, 2018
Applicant:

Immunovaccine Technologies Inc., Dartmouth, CA;

Inventors:

Marc Mansour, Halifax, CA;

Lisa Diana MacDonald, Halifax, CA;

Genevieve Mary Weir, Dartmouth, CA;

Leeladhar Sammatur, Irvine, CA (US);

Kendall Sharp, Halifax, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/145 (2006.01); A61K 9/127 (2006.01); A61K 39/07 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 9/127 (2013.01); A61K 39/07 (2013.01); A61K 39/099 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55566 (2013.01); C12N 2760/16134 (2013.01);
Abstract

The invention provides compositions comprising liposomes, an antigen capable of inducing a humoral immune response, a carrier comprising a continuous phase of a hydrophobic substance, and an adjuvant that activates or increases the activity of TLR2. The invention also provides uses for such compositions in inducing a humoral response and methods for their use in the treatment of a disease, disorder or ailment ameliorated by a humoral immune response.


Find Patent Forward Citations

Loading…